샘플 요청 목록

 카트 문의
시장보고서
상품코드
1836307

암 생검 시장 : 제품별, 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Cancer Biopsy Market, By Product, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 388 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암 생검 시장 규모는 2024년 322억 6,812만 달러로 평가되며 2025년부터 2032년까지 CAGR 8.23%로 성장할 것으로 예상됩니다.

암 생검은 암이 의심되는 부위에서 소량의 조직, 체액, 세포 샘플을 채취하여 검사실에서 검사하여 암을 진단하는 의료행위입니다. 이 검사는 암의 유무, 종류, 병기를 판단하는 데 도움이 되며, 의사가 적절한 치료 계획을 세우는 데 도움이 됩니다. 생검은 이상 부위에 따라 침생검, 수술적 생검, 내시경적 생검 등 다양한 방법으로 시행됩니다.

암 생검 시장 - 시장 역학

전 세계 암 발병률 증가로 시장 수요 증가 전망

전 세계 암 생검 시장은 전 세계 암 유병률의 급격한 증가에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면, 2022년에는 2,000만 명에 가까운 신규 암 환자가 발생할 것으로 예상되어 진단 솔루션의 시급성이 부각되고 있습니다. 정부와 보건 기관은 조기 발견을 중시하고 있으며, 이는 생검 수요를 직접적으로 촉진하고 있습니다. 그러나 액체 생검이나 차세대 염기서열 분석과 같은 첨단 기술은 여전히 고가이며, 중저소득 국가에서는 접근성이 제한되어 있습니다.

기회 측면에서는 액체 생검의 채택이 가속화되고 있습니다. 미국 식품의약국(FDA)은 이미 40개 이상의 표적 암 치료제의 동반진단 약물을 승인하여 보다 광범위한 임상 통합을 보장하고 있습니다. 또한, 미국의 암 문샷 계획, 유럽연합의 암 퇴치 계획 등 정부의 대규모 노력으로 암 연구와 혁신에 대한 자금이 대폭 확대되고 있습니다. 이러한 힘들이 결합하여, 발병률 상승과 지원적인 정책이 비용 문제를 능가하는 시장 환경이 형성되어 지속적인 세계 성장을 보장하고 있습니다.

암 생검 시장 - 세분화 분석:

암 생검 세계 시장은 제품, 유형, 용도, 최종사용자, 지역별로 분류됩니다.

제품은 서비스, 장비, 키트 및 소모품의 3가지로 분류됩니다. 서비스 부문은 고급 진단 검사, 병리학적 서비스에 대한 수요 증가, 전 세계적으로 최소침습적 생검술의 채택이 증가함에 따라 예측 기간 동안 주요 시장 점유율을 차지할 것으로 예상됩니다.

시장은 용도별로 유방암, 자궁경부암, 대장암, 전립선암, 폐암, 혈액암, 피부암, 신장암, 난소암, 췌장암, 간암, 기타 등 12가지 카테고리로 분류됩니다. 이 중 유방암 분야는 높은 유병률, 검진 프로그램 증가, 첨단 진단 기술 도입 확대 등을 배경으로 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

암 생검 시장 - 지리적 인사이트

북미 암 생검 시장은 40% 이상의 점유율로 세계 시장을 독점하고 있습니다. 이 지역의 선두는 높은 발병률과 강력한 정책 프레임워크에 의해 강화되고 있습니다. 미국 암 통계에 따르면, 2022년에는 27만 9,731명의 신규 여성 유방암 환자가 보고되었으며, 암 발병률은 해마다 증가하고 있습니다.

차세대 시퀀서에 대한 메디케어 보험 적용과 Guardant360 CDx와 같은 액체 생검 검사에 대한 FDA 승인은 그 채택을 더욱 가속화합니다. 유럽에서는 EU의 'Beating Cancer Plan'이 2025년까지 대상자의 90%가 검진을 받을 수 있도록 하는 것을 목표로 하고 있으며, 영국 NHS는 조기 진단을 향상시키기 위해 액체 생검을 시범적으로 확대 시행하고 있습니다. 아시아태평양은 가장 빠르게 성장하는 시장입니다. 인도 ICMR은 2024년 153만 명의 신규 확진자가 발생할 것으로 예측하고 있으며, 일본은 2022년 약 101만 명의 신규 확진자가 발생했다고 보고했습니다. 정책적 지원, 명확한 상환, 환자 수 증가 등을 종합하면, 북미가 선두를 유지하는 가운데 유럽과 아시아태평양이 빠르게 격차를 좁혀가고 있습니다.

암 생검 시장 - 경쟁 상황:

조기 및 정확한 암 진단에 대한 수요가 증가함에 따라 생검 솔루션의 기술 혁신과 효율성 향상을 위한 기업들의 노력이 계속되고 있습니다. 시장 진입 기업들은 최소침습적 생검 기술 개발, 고급 이미지 가이던스 통합, 정확도를 높이기 위한 분자 검사 능력 향상에 주력하고 있습니다. 임상 적용을 확대하기 위해 연구 기관 및 의료 서비스 제공자와의 전략적 제휴를 추진하고 있습니다. 또한, 각 업체들은 자동화, 디지털 병리, AI를 활용한 진단에 투자하여 결과의 신속성, 정확성 강화, 경쟁 우위 확보를 목표로 하고 있습니다.

목차

제1장 암 생검 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 암 생검 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 암 생검 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 암 생검 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 암 생검 시장 구도

  • 암 생검 시장 점유율 분석(2024년)
  • 내역 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 암 생검 시장 - 제품별

  • 개요
    • 부문 점유율 분석 : 제품별
    • 서비스
    • 기기
    • 키트·소모품

제8장 암 생검 시장 - 유형별

  • 개요
    • 부문 점유율 분석 : 유형별
    • 액체 생검
      • 코어 침 생검(CNB)
      • 세침 흡인법(FNA)
    • 조직 생검
      • 외과적 생검
      • 침 생검
    • 기타

제9장 암 생검 시장 - 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • 유방암
    • 자궁경부암
    • 대장암
    • 전립선암
    • 폐암
    • 혈액암
    • 피부암
    • 신장암
    • 난소암
    • 췌장암
    • 간암
    • 기타

제10장 암 생검 시장 - 최종사용자별

  • 개요
    • 부문 점유율 분석 : 최종사용자별
    • 병원
    • 진단 센터
    • 암 연구 센터
    • 연구·학술

제11장 암 생검 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 암 생검 업계

  • 경쟁 대시보드
    • Competitive Benchmarking
    • Competitive Positioning
  • 기업 개요
    • QIAGEN
    • ANGLE plc
    • Illumina, Inc.
    • BD(Becton, Dickinson and Company)
    • Hologic, Inc.
    • Myriad Genetics, Inc.
    • Biocept, Inc.
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GRAIL, Inc.
    • Lucence Health Inc.
    • Guardant Health Inc.
    • Freenome Holdings, Inc.
    • Exact Sciences Corporation
    • Biodesix(Integrated Diagnostics)
    • Epigenomics AG
    • Oncimmune
    • HelioHealth(Laboratory for Advanced Medicine)
    • Chronix Biomedical, Inc.
    • Genesystems, Inc.(Genesys Biolabs)
    • Personal Genome Diagnostics Inc.
    • Personalis Inc.
    • Natera, Inc.
    • 기타

제13장 애널리스트의 전방위적 전망

KSM 25.10.30

Cancer biopsy market size was valued at US$ 32,268.12 Million in 2024, expanding at a CAGR of 8.23% from 2025 to 2032.

A cancer biopsy is a medical procedure used to diagnose cancer by removing a small sample of tissue, fluid, or cells from a suspicious area in the body for laboratory examination. This test helps determine the presence, type, and stage of cancer, guiding doctors in creating appropriate treatment plans. Biopsies can be performed using different methods such as needle biopsy, surgical biopsy, or endoscopic biopsy, depending on the location of the abnormality.

Cancer Biopsy Market- Market Dynamics

Increasing prevalence of cancer among people globally to propel market demand

The global cancer biopsy market is driven by the sharp rise in cancer prevalence worldwide. According to the World Health Organization (WHO), nearly 20 million new cancer cases were recorded in 2022, highlighting the urgency for diagnostic solutions. Governments and health agencies are emphasizing early detection, which directly fuels biopsy demand. However, advanced techniques such as liquid biopsy and next-generation sequencing remain costly, restricting access in low- and middle-income countries.

On the opportunity side, liquid biopsy adoption is accelerating: the U.S. Food and Drug Administration (FDA) has already approved more than 40 companion diagnostics for targeted cancer therapies, ensuring wider clinical integration. Additionally, large-scale government initiatives-such as the U.S. Cancer Moonshot program and the European Union's Beating Cancer Plan-are significantly boosting funding for cancer research and innovation. These combined forces create a market landscape where rising incidence and supportive policy outweigh cost challenges, ensuring sustained global growth.

Cancer Biopsy Market- Segmentation Analysis:

The Global Cancer Biopsy Market is segmented on the basis of Product, Type, Application, End User, and Region.

The market is divided into three categories based on Product: services, instruments, and kits & consumables. The services segment is expected to hold the major market share during the forecast period, driven by rising demand for advanced diagnostic testing, pathology services, and increasing adoption of minimally invasive biopsy procedures worldwide.

The market is divided into twelve categories based on Application: breast cancer, cervical cancer, colorectal cancer, prostate cancer, lung cancer, blood cancer, skin cancer, kidney cancer, ovarian cancer, pancreatic cancer, liver cancer, and others. Among these, the breast cancer segment is expected to hold the largest market share during the forecast period, driven by its high prevalence, rising screening programs, and growing adoption of advanced diagnostic techniques

Cancer Biopsy Market- Geographical Insights

North America cancer biopsy market dominated the global market with over 40% share. The region's lead is reinforced by high incidence rates and strong policy frameworks. According to U.S. Cancer Statistics, 279,731 new female breast cancer cases were reported in 2022, and total cancer incidence continues to rise year-on-year.

Medicare coverage for next-generation sequencing and FDA approvals of liquid biopsy tests, such as Guardant360 CDx, further accelerate adoption. In Europe, the EU Beating Cancer Plan aims to ensure 90% of eligible citizens are offered screening by 2025, while NHS England has expanded liquid biopsy pilots to improve early diagnosis. Asia Pacific is the fastest-growing market: India's ICMR projects 1.53 million new cases in 2024, and Japan reported around 1.01 million new cases in 2022, both significantly expanding biopsy demand. Collectively, policy backing, reimbursement clarity, and rising case volumes sustain North America's lead while Europe and Asia Pacific rapidly close the gap.

Cancer Biopsy Market- Competitive Landscape:

Rising demand for early and accurate cancer diagnosis is driving companies to enhance innovation and efficiency in biopsy solutions. Market participants are focusing on developing minimally invasive biopsy techniques, integrating advanced imaging guidance, and improving molecular testing capabilities to increase precision. Strategic collaborations with research institutions and healthcare providers are being pursued to expand clinical applications. In addition, companies are investing in automation, digital pathology, and AI-powered diagnostics to accelerate results, strengthen accuracy, and gain a competitive advantage.

Recent Developments:

In April 2025, Labcorp launched molecular residual disease and liquid biopsy testing, offering advanced genomic insights to support personalized cancer treatment, improve disease monitoring, and aid in early relapse detection for better patient outcomes across diverse cancer types.

In June 2025, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to introduce advanced liquid biopsy testing in the UAE, enhancing cancer diagnosis, treatment decisions, and biomarker testing for improved precision oncology outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • QIAGEN
  • ANGLE plc
  • Illumina, Inc.
  • BD (Becton, Dickinson and Company)
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Biocept, Inc.
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Lucence Health Inc.
  • Guardant Health Inc.
  • Freenome Holdings, Inc.
  • Exact Sciences Corporation
  • Biodesix (Integrated Diagnostics)
  • Epigenomics AG
  • Oncimmune
  • HelioHealth (Laboratory for Advanced Medicine)
  • Chronix Biomedical, Inc.
  • Genesystems, Inc. (Genesys Biolabs)
  • Personal Genome Diagnostics Inc.
  • Personalis Inc.
  • Natera, Inc.
  • Others

GLOBAL CANCER BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Services
  • Instruments
  • Kits & Consumables

GLOBAL CANCER BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsies
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration (FNA)
  • Tissue Biopsies
  • Surgical Biopsies
  • Needle Biopsies
  • Others

GLOBAL CANCER BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Blood Cancer
  • Skin Cancer
  • Kidney Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Others

GLOBAL CANCER BIOPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Research & Academics

GLOBAL CANCER BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Biopsy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Biopsy Market Snippet by Product
    • 2.1.2. Cancer Biopsy Market Snippet by Type
    • 2.1.3. Cancer Biopsy Market Snippet by Application
    • 2.1.4. Cancer Biopsy Market Snippet by End User
    • 2.1.5. Cancer Biopsy Market Snippet by Country
    • 2.1.6. Cancer Biopsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Biopsy Key Market Trends

  • 3.1. Cancer Biopsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Biopsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Biopsy Market Opportunities
  • 3.4. Cancer Biopsy Market Future Trends

4. Cancer Biopsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Biopsy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cancer Biopsy Market Landscape

  • 6.1. Cancer Biopsy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Biopsy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Services
    • 7.1.3. Instruments
    • 7.1.4. Kits & Consumables

8. Cancer Biopsy Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsies
      • 8.1.2.1. Core Needle Biopsy (CNB)
      • 8.1.2.2. Fine Needle Aspiration (FNA)
    • 8.1.3. Tissue Biopsies
      • 8.1.3.1. Surgical Biopsies
      • 8.1.3.2. Needle Biopsies
    • 8.1.4. Others

9. Cancer Biopsy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Cervical Cancer
    • 9.1.4. Colorectal Cancer
    • 9.1.5. Prostate Cancer
    • 9.1.6. Lung Cancer
    • 9.1.7. Blood Cancer
    • 9.1.8. Skin Cancer
    • 9.1.9. Kidney Cancer
    • 9.1.10. Ovarian Cancer
    • 9.1.11. Pancreatic Cancer
    • 9.1.12. Liver Cancer
    • 9.1.13. Others

10. Cancer Biopsy Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Centers
    • 10.1.4. Cancer Research Centers
    • 10.1.5. Research & Academics

11. Cancer Biopsy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cancer Biopsy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cancer Biopsy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cancer Biopsy Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cancer Biopsy Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cancer Biopsy Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cancer Biopsy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. QIAGEN
    • 12.2.2. ANGLE plc
    • 12.2.3. Illumina, Inc.
    • 12.2.4. BD (Becton, Dickinson and Company)
    • 12.2.5. Hologic, Inc.
    • 12.2.6. Myriad Genetics, Inc.
    • 12.2.7. Biocept, Inc.
    • 12.2.8. Danaher
    • 12.2.9. Thermo Fisher Scientific, Inc.
    • 12.2.10. F. Hoffmann-La Roche Ltd.
    • 12.2.11. GRAIL, Inc.
    • 12.2.12. Lucence Health Inc.
    • 12.2.13. Guardant Health Inc.
    • 12.2.14. Freenome Holdings, Inc.
    • 12.2.15. Exact Sciences Corporation
    • 12.2.16. Biodesix (Integrated Diagnostics)
    • 12.2.17. Epigenomics AG
    • 12.2.18. Oncimmune
    • 12.2.19. HelioHealth (Laboratory for Advanced Medicine)
    • 12.2.20. Chronix Biomedical, Inc.
    • 12.2.21. Genesystems, Inc. (Genesys Biolabs)
    • 12.2.22. Personal Genome Diagnostics Inc.
    • 12.2.23. Personalis Inc.
    • 12.2.24. Natera, Inc.
    • 12.2.25. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제